Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact

Abstract Background Bacterial vaginosis (BV) increases HIV acquisition risk, potentially by eliciting genital inflammation. After BV treatment, the vaginal administration of LACTIN-V, a live biotherapeutic containing the Lactobacillus crispatus strain CTV-05, reduced BV recurrence and vaginal inflam...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eric Armstrong, Anke Hemmerling, Steve Miller, Sanja Huibner, Maria Kulikova, Emily Crawford, Gloria R. Castañeda, Bryan Coburn, Craig R. Cohen, Rupert Kaul
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-06-01
coleção:	Microbiome
Acesso em linha:	https://doi.org/10.1186/s40168-024-01828-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!